Purchase Order 36C26126P0594
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 15, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetic devices to support the VA Palo Alto Health Care System. This award carries no set-aside designation and represents a restocking procurement executed under the company's existing five-year, $6.5 million indefinite delivery...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 29, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants restocking. The contract, with performance completion by April 28, 2026, supports the VA Palo Alto Health Care System's cardiac surgical program by replenishing inventory of specialized cardiovascular devices. This award carries no set-aside designation...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on March 17, 2026, carries an ultimate completion date of June 16, 2026, and will be performed in San Francisco, California. This procurement carries no set-aside designation and reflects the VA's continued reliance on Edwards...
- Edwards Lifesciences LLC was awarded a $65,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) on October 28, 2025, for the procurement of transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract is scheduled for completion by January 27, 2026, and will be performed in San Francisco, California. This award was made without a set-aside designation and represents Edwards Lifesciences LLC's continued role as a specialized...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC on September 18, 2025, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which is not set-aside designated, will be performed in San Francisco, California, with a completion date of December 17, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
- Edwards Lifesciences LLC received a firm fixed-price purchase order valued at $68,000 from Veterans Integrated Service Network 21 (VISN 21) for two transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on February 17, 2026, with completion targeted for the same date, will support cardiac surgical services at the VA Palo Alto Health Care System in Palo Alto, California. This procurement carries no set-aside designation and represents a specialized medical device...
- Edwards Lifesciences LLC has been awarded a $32.5K firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on December 30, 2025, has an ultimate completion date of March 29, 2026, and will be performed in San Francisco, California. No set-aside designation was used for this procurement, and Edwards Lifesciences LLC serves as both the prime contractor and sole...
- Edwards Lifesciences LLC received a $32.5K firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics restocking. The contract, awarded on February 9, 2026, carries an ultimate completion date of May 8, 2026, with performance taking place at the VA Palo Alto Health Care System in San Francisco, California. No set-aside designation was utilized...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a purchase order contract to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the procurement of TAVR (Transcatheter Aortic Valve Replacement) prosthetics. The $97,500.00 firm fixed price contract has a completion date of June 21, 2024 and will support healthcare services at VA facilities in VISN (Veterans Integrated Service Network) 21, which covers the San Francisco, CA area....
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San...
The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on April 1, 2026, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract carries no set-aside designation and will be performed in San Francisco, California, with a completion date of June 30, 2026. This purchase order is issued under Edwards Lifesciences LLC's existing five-year indefinite delivery contract with VISN 21, valued at $6.5 million and effective through December 31, 2030, which establishes a consignment inventory model for specialized cardiac devices at the VA Palo Alto Health Care System. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, is a leading manufacturer of advanced cardiovascular medical devices, including transcatheter heart valves and surgical implants. The company has received over 200 prime federal contract awards from the Department of Veterans Affairs since 2025, primarily for TAVR systems and related cardiac technologies. As the exclusive supplier of these specialized medical technologies, Edwards Lifesciences LLC holds a critical role in supporting the VA's cardiac surgical programs and veteran patient outcomes across multiple integrated service networks, with particularly significant procurement volumes from VISN 21, VISN 23, and VISN 17.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 3/31/26 |